Warning letter
Transplant Resource Center of Maryland, Inc.: warning letter of Jan 13, 2003
FDA warning letter UCM147266 · Baltimore District Office
Key facts
| Reference number | UCM147266 |
|---|---|
| Company | Transplant Resource Center of Maryland, Inc. |
| Subject | Human Tissue Intended for Transplantation |
| Issue date | Jan 13, 2003 |
| Posted date | Jan 13, 2003 |
| Issuing office | Baltimore District Office |
| Product type | Unknown |
| Country | 3 |
| Inspection city | Halethorpe |
| Inspection ZIP | 21227-3551 |
| Inspection start date | Aug 30, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: